Evidence map›Paper›PMID 34685512›Full record

ReviewCells2021

Towards Understanding the Direct and Indirect Actions of Growth Hormone in Controlling Hepatocyte Carbohydrate and Lipid Metabolism.

Mari C Vázquez-Borrego, Mercedes Del Rio-Moreno, Rhonda D Kineman

Open access · goldAbstract readReview
In one paragraph

Review in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Sex Hormones and Metabolic Dysfunction-Associated Steatotic Liver Disease.International journal of molecular sciences · 2025
    Review
  5. Article
  6. Article
  7. Liver-specific actions of GH and IGF1 that protect against MASLD.Nature reviews. Endocrinology · 2025 · on this map
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Growth hormone and nonalcoholic fatty liver disease.Immunometabolism (Cobham, Surrey) · 2023 · on this map
    Review
  14. Article
  15. Important Hormones Regulating Lipid Metabolism.Molecules (Basel, Switzerland) · 2022
    Review
  16. Growth Hormone and Insulin-Like Growth Factor 1 Regulation of Nonalcoholic Fatty Liver Disease.The Journal of clinical endocrinology and metabolism · 2022 · on this map
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Mari C Vázquez-BorregoDepartment of Medicine, Section of Endocrinology, Diabetes, and Metabolism, University of Illinois at Chicago and Research and Development Division, Jesse Brown VA Medical Center, Chicago, IL 60612, USA.
Mercedes Del Rio-MorenoDepartment of Medicine, Section of Endocrinology, Diabetes, and Metabolism, University of Illinois at Chicago and Research and Development Division, Jesse Brown VA Medical Center, Chicago, IL 60612, USA.
Rhonda D KinemanDepartment of Medicine, Section of Endocrinology, Diabetes, and Metabolism, University of Illinois at Chicago and Research and Development Division, Jesse Brown VA Medical Center, Chicago, IL 60612, USA.
University of Illinois Chicago · US

Funding

Elucidating the role of the FXR-PTEN-PI3K-AKT-mTOR axis in liver progenitor cell-driven liver regenerationR01DK101426 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SHIN, DONGHUN · 2014 to 2023
$3.8M
Hormonal Regulation of Liver MetabolismR01DK116878 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI KINEMAN, RHONDA D · 2019 to 2022
$1.5M
Hormonal control of NASH development and progressionI01BX004448 · VA · JESSE BROWN VA MEDICAL CENTER · PI KINEMAN, RHONDA D · 2019 to 2025
–
BLRD Research Career Scientist Award ApplicationIK6BX005382 · VA · JESSE BROWN VA MEDICAL CENTER · PI KINEMAN, RHONDA D · 2021 to 2025
–
BLRD VA I01 BX004448BLRD VA IK6 BX005382NIDDK NIH HHS R01 DK101426NIDDK NIH HHS R01 DK116878Office of Research and Development BX001114
6 · The paper itself

Abstract

Growth hormone (GH) is critical for achieving normal structural growth. In addition, GH plays an important role in regulating metabolic function. GH acts through its GH receptor (GHR) to modulate the production and function of insulin-like growth factor 1 (IGF1) and insulin. GH, IGF1, and insulin act on multiple tissues to coordinate metabolic control in a context-specific manner. This review will specifically focus on our current understanding of the direct and indirect actions of GH to control liver (hepatocyte) carbohydrate and lipid metabolism in the context of normal fasting (sleep) and feeding (wake) cycles and in response to prolonged nutrient deprivation and excess. Caveats and challenges related to the model systems used and areas that require further investigation towards a clearer understanding of the role GH plays in metabolic health and disease are discussed.

Indexed as

Carbohydrate MetabolismGrowth HormoneHepatocytesHumansLipid MetabolismLiverReceptors, SomatotropinGrowth HormoneReceptors, Somatotropincarbohydratesgrowth hormonehepatocyteIGF1insulinlipidsmetabolism

Identifiers

PMID34685512
PMCPMC8533955
OpenAlexW3202465970

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.